Score Overview
Explore the 2021 public Archive ranking →
Where LivaNova PLC has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- LIVN
1998: 82.0% · 2021: 87.0% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 76.99 | — |
1 Year2025-09-29 | $ 52.33 | 47.12% |
5 Years2021-09-29 | $ 80.20 | -4.00% |
10 Years2016-09-29 | $ 59.97 | 28.38% |
20 Years2006-09-29 | $ 17.53 | 339.19% |
30 Years1996-09-26 | $ 6.25 | 12x |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-26 |
|---|---|---|---|---|---|---|
| Price | $ 76.99 | $ 52.33 | $ 80.20 | $ 59.97 | $ 17.53 | $ 6.25 |
| Return | — | 47.12% | -4.00% | 28.38% | 339.19% | 12x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 1.47B | $ 188M | $ 516M |
| 2025 | $ 1.38B | -$ 242M | $ 635M |
| 2024 | $ 1.25B | $ 63M | $ 428M |
| 2023 | $ 1.15B | $ 17M | $ 266M |
| 2022 | $ 1.02B | -$ 86M | $ 214M |
| 2021 | $ 1.03B | -$ 135M | $ 207M |
| 2020 | $ 934M | -$ 348M | $ 252M |
| 2019 | $ 1.08B | -$ 157M | $ 61M |
| 2018 | $ 1.10B | -$ 189M | $ 47M |
| 2017 | $ 1.01B | -$ 25M | $ 93M |
| 2016 | $ 1.21B | -$ 62M | $ 39M |
| 2015 | $ 291M | $ 57M | $ 119M |
| 2014 | $ 282M | $ 54M | $ 128M |
| 2013 | $ 282M | $ 54M | $ 128M |
| 2012 | $ 254M | $ 46M | $ 135M |
| 2011 | $ 218M | $ 36M | $ 96M |
| 2010 | $ 190M | $ 46M | $ 89M |
| 2009 | $ 167M | $ 78M | $ 85M |
| 2008 | $ 143M | $ 26M | $ 54M |
| 2007 | $ 121M | -$ 10M | $ 62M |
| 2006 | $ 130M | -$ 51M | $ 89M |
| 2005 | $ 123M | -$ 59M | $ 92M |
| 2004 | $ 103M | -$ 12M | $ 61M |
| 2003 | $ 110M | $ 6M | $ 58M |
| 2002 | $ 104M | $ 5M | $ 57M |
| 2001 | $ 70M | -$ 26M | $ 39M |
| 2000 | $ 43M | $ 43M | |
| 1999 | $ 47M | -$ 3M | $ 16M |
| 1998 | $ 29M | -$ 12M | $ 20M |
| 1997 | $ 14M | -$ 14M | $ 200K |
| 1996 | $ 1M | -$ 11M | $ 18M |
| 1995 | $ 1M | -$ 10M | $ 2M |
| 1994 | $ 1M | -$ 7M | $ 6M |
| IPO1993 | $ 400K | -$ 5M | $ 4M |
LivaNova PLC fundamental performance
Between 2020 and 2025, revenue grew from $ 934M to $ 1.38B and net income went from -$ 348M to -$ 242M. Revenue increased in 4 of those 5 years; net income in 4.
Across LivaNova PLC's full reported history, from 1993 to 2025, revenue grew from $ 400K to $ 1.38B and net income went from -$ 5M to -$ 242M. Revenue increased in 73% of the years measured; net income in 58%.
LivaNova PLC currently holds a 20-year HDB Score of 5.4 out of 10. How the HDB Score is calculated.
Membership
Continue LIVN’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Ligand Pharmaceuticals IncorporatedLGND· revenue grew in 75% of years
Bristol-Myers Squibb CompanyBMY· revenue grew in 65% of years
Corcept Therapeutics IncorporatedCORT· revenue grew in 89% of years
Bruker CorporationBRKR· revenue grew in 80% of years
National Research CorpNRC· revenue grew in 85% of years
